Detection of benign granular cell tumor of the breast via 18F-PSMA-PET/CT in a patient with very high-risk prostate cancer: A case report

被引：0
作者：
Ghabili, Kamyar [1 ]
Rajyaguru, Rushi [1 ]
De La Plante, Alexandra [2 ]
Widders, Kristine L. [3 ]
Chetlen, Alison L. [1 ]
Choe, Angela I. [1 ]
Kasales, Claudia J. [1 ]
机构：
[1] Penn State Hlth Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA USA
[2] Penn State Hlth Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA USA
[3] Penn State Hlth Milton S Hershey Med Ctr, Dept Surg, Hershey, PA USA
来源：
SAGE OPEN MEDICAL CASE REPORTS | 2024年 / 12卷
关键词：
Breast; granular cell tumor; positron emission tomography; prostate cancer; prostate-specific membrane antigen;
D O I：
10.1177/2050313X241275826
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Incidental extra-prostatic prostate-specific membrane antigen (PSMA) uptake on initial staging positron emission tomography/computed tomography (PET/CT) scans poses diagnostic challenges, as it can be associated with various benign and malignant lesions. We present the case of a 68-year-old man with very high-risk prostate cancer who was incidentally discovered to have a benign granular cell tumor in the breast initially detected on PSMA-PET/CT. Imaging studies and biopsy were pivotal in the diagnosis, as the tumor's appearance was concerning for breast carcinoma. Recognizing extra-prostatic PSMA uptake in the breast, particularly in patients with prostate cancer, is crucial for guiding appropriate management, accurately interpreting subsequent imaging findings, and assessing radiologic-pathologic correlation.
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
    Elschot, Mattijs
    Selnaes, Kirsten M.
    Sandsmark, Elise
    Kruger-Stokke, Brage
    Storkersen, Oystein
    Giskeodegard, Guro F.
    Tessem, May-Britt
    Moestue, Siver A.
    Bertilsson, Helena
    Bathen, Tone F.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 762 - 768
  • [32] Diagnostic Performance of 99mTc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18F-PSMA-1007 PET/CT
    Vargas-Ahumada, Joel
    Gonzalez-Rueda, Sofia Denisse
    Sinisterra-Solis, Fabio Andres
    Casanova-Trivino, Pamela
    Pitalua-Cortes, Quetzali
    Soldevilla-Gallardo, Irma
    Scavuzzo, Anna
    Jimenez-Rios, Miguel Angel
    Garcia-Perez, Francisco Osvaldo
    CANCERS, 2023, 15 (24)
  • [33] 18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
    Kjolhede, H.
    Ahlgren, G.
    Almquist, H.
    Liedberg, F.
    Lyttkens, K.
    Ohlsson, T.
    Bratt, O.
    WORLD JOURNAL OF UROLOGY, 2014, 32 (04) : 965 - 970
  • [34] 18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
    H. Kjölhede
    G. Ahlgren
    H. Almquist
    F. Liedberg
    K. Lyttkens
    T. Ohlsson
    O. Bratt
    World Journal of Urology, 2014, 32 : 965 - 970
  • [35] Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
    Jacob Ingvar
    Erland Hvittfeldt
    Elin Trägårdh
    Athanasios Simoulis
    Anders Bjartell
    EJNMMI Research, 12
  • [36] Feasibility of Different Tumor Delineation Approaches for 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
    Mittlmeier, Lena M.
    Brendel, Matthias
    Beyer, Leonie
    Albert, Nathalie L.
    Todica, Andrei
    Zacherl, Mathias J.
    Wenter, Vera
    Herlemann, Annika
    Kretschmer, Alexander
    Ledderose, Stephan T.
    Schmidt-Hegemann, Nina-Sophie
    Kunz, Wolfgang G.
    Ricke, Jens
    Bartenstein, Peter
    Ilhan, Harun
    Unterrainer, Marcus
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
    Ingvar, Jacob
    Hvittfeldt, Erland
    Tragardh, Elin
    Simoulis, Athanasios
    Bjartell, Anders
    EJNMMI RESEARCH, 2022, 12 (01)
  • [38] Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
    Simona Malaspina
    Mikael Anttinen
    Pekka Taimen
    Ivan Jambor
    Minna Sandell
    Irina Rinta-Kiikka
    Sami Kajander
    Jukka Schildt
    Ekaterina Saukko
    Tommi Noponen
    Jani Saunavaara
    Peter B. Dean
    Roberto Blanco Sequeiros
    Hannu J. Aronen
    Jukka Kemppainen
    Marko Seppänen
    Peter J. Boström
    Otto Ettala
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2951 - 2959
  • [39] Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection
    Droghetti, Matteo
    Bianchi, Lorenzo
    Presutti, Massimiliano
    Vetrone, Luigia
    Farolfi, Andrea
    Mei, Riccardo
    Giunchi, Francesca
    Degiovanni, Alessio
    Mottaran, Angelo
    Piazza, Pietro
    Cangemi, Danilo
    Castellucci, Paolo
    D'Errico, Antonietta
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Fanti, Stefano
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] 18F-DCFPyL PET/CT in Newly Diagnosed Prostate Cancer: Diagnostic Value of Intraprostatic PSMA Uptake in Risk Classification of Prostate Cancer
    Zhou, Shuoming
    Liu, Tiantian
    Zhu, Ziqiang
    Zhang, Lin
    Qian, Subo
    Fu, Hongliang
    Cao, Qifeng
    Kang, Jian
    FRONTIERS IN ONCOLOGY, 2022, 12
12345